Search
Type
Audience
Category
Issue
Last updated
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archive checkbox.
Displaying 1 - 15 of 414 items.
Shortage of infant formulas for babies with food allergies: what you should know and do
UPDATE: June 29, 2022
There continues to be a national shortage of specialized infant formulas for infants with food allergies and certain medical conditions. This includes extensively hydrolyzed formulas and amino acid-based formulas. There is no…
AlertPublic advisory | 2022-06-29
Unauthorized health products seized from three herbal medicine stores in Calgary, Alberta
UPDATE (June 15, 2022):
Health Canada is warning consumers about additional unauthorized products seized from three herbal medicine stores in Calgary, Alberta, after testing found they contain drugs that are not listed on the product label, which may…
AlertPublic advisory | 2022-06-16
Unauthorized products may pose serious health risks
Health Canada is advising Canadians about unauthorized health products that may pose serious health risks. The table is updated when Health Canada finds unauthorized health products that are promoted for sexual enhancement, weight loss, as a workout aid…
AlertPublic advisory | 2022-06-16
Distribution of a New Presentation of SPIKEVAX (elasomeran) COVID-19 Vaccine (0.10 mg/mL in 2.5 mL multidose vial) with English-only Vial and Carton Labels
A new presentation of SPIKEVAX (elasomeran) with a concentration of 0.10 mg/mL in a 2.5 mL multidose vial was authorized on June 01, 2022. In order to provide rapid access to the new presentation of SPIKEVAX (0.10 mg/mL, 2.5 mL multidose vial), Moderna…
AlertHealth professional risk communication | 2022-06-06
Unauthorized products may pose serious health risks (March 26, 2021 to June 3, 2022)
Health Canada is advising Canadians about unauthorized health products that may pose serious health risks. The table is updated when Health Canada finds unauthorized health products that are promoted for sexual enhancement, weight loss, as a workout aid…
AlertPublic advisory | 2022-06-03
Health Canada warns of three DigitDots magnet sets that pose serious risks
Health Canada is warning Canadians of the serious danger posed by DigitDots magnet sets that were sold to Canadians online by HD Premier.
These sets contain small, powerful magnets that can be easily swallowed by children of all ages, posing serious…
AlertPublic advisory | 2022-05-12
Health Canada reminds Canadians that plasma pens are unauthorized and may pose health risks, following complaints involving Calgary and North York spas
August 25, 2019
For immediate release
OTTAWA – Health Canada is reminding Canadians that plasma pens are not authorized for sale in Canada and that these devices may pose health risks. Health Canada is also underlining that consumers should be wary…
AlertInformation update | 2022-05-11
Plasma pens are not authorized in Canada and may pose health risks
November 26, 2018
For immediate release
OTTAWA – Health Canada is advising consumers that plasma pens (also known as “fibroblast” devices) promoted for cosmetic skin treatments such as eyelid lifts, wrinkle reduction and…
AlertInformation update | 2022-05-11
COMIRNATY (COVID-19 Vaccine, mRNA, also referred to as Pfizer-BioNTech COVID-19 Vaccine): New Formulation/Presentation for Use in Individuals 12 Years of Age and Older
UPDATED INFORMATION – June 10, 2022
Further to the communication below, issued on May 9, 2022, Health Canada has issued a new DIN (i.e. DIN 02527863) for COMIRNATY (COVID-19 Vaccine, mRNA), 30 mcg/0.3 mL, which has a GRAY vial cap and GRAY label…
AlertHealth professional risk communication | 2022-05-09
One lot of Pharmasave Advanced Relief Eye Drops and Compliments Advanced Relief Eye Drops recalled because of a packaging error that may pose health risks
Teva Canada Ltd. is recalling one lot each of Pharmasave Advanced Relief Eye Drops and Compliments Advanced Relief Eye Drops because of a packaging error. Some bottles may contain ingredients that are not listed on the label and that may pose health…
AlertPublic advisory | 2022-05-07
Apotex recalls Apo-Acyclovir tablets due to a nitrosamine impurity
Apotex Inc. is recalling certain lots of Apo-Acyclovir (acyclovir) tablets, in 200 mg and 800 mg strengths, due to the presence of a nitrosamine impurity (N-nitrosodimethylamine [NDMA]) above the acceptable level.
Apo-Acyclovir is a…
AlertPublic advisory | 2022-04-28
Pfizer recalls Accupril blood pressure tablets due to a nitrosamine impurity
UPDATE: April 21, 2022 – Pfizer recalls Accupril blood pressure tablets due to a nitrosamine impurity
Pfizer Canada ULC is recalling all lots of the prescription drug Accupril (quinapril hydrochloride) in 10 mg, 20 mg and 40 mg strengths due to the…
AlertPublic advisory | 2022-04-21
Health Canada warns about certain hand sanitizers that may pose health risks (Part 2 – March 31, 2021 to present)
Certain lots of hand sanitizers do not meet Health Canada requirements. Issues include:
containing (or possibly containing) ingredients that are not permitted by Health Canada;
containing undeclared impurities at elevated levels;
improper…
AlertPublic advisory | 2022-04-20
Sotrovimab for Injection - Risk of Treatment Failure due to Circulation of SARS-CoV-2 Omicron BA.2 Subvariant
Sotrovimab, 500 mg IV, is unlikely to maintain efficacy against the Omicron BA.2 subvariant. Sotrovimab demonstrates reduced in vitro neutralization against the Omicron BA.2 subvariant.
Audience
Healthcare professionals responsible…
AlertHealth professional risk communication | 2022-04-14
Distribution of EVUSHELD (tixagevimab and cilgavimab for injection) with English-Only Vial and Carton Labels
EVUSHELD (tixagevimab and cilgavimab for injection) was authorized by Health Canada on April 14, 2022. In order to provide rapid access to EVUSHELD in the context of the global COVID-19 pandemic, AstraZeneca will distribute product vials and cartons with…
AlertHealth professional risk communication | 2022-04-14